Hofheim, Germany

Gerhard Hessler

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh, Bayer Aktiengesellschaft. Active years: 2004-2024.

USPTO Granted Patents = 28 

% Patents Active = 35.7

 

 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 212(Granted Patents)


Location History:

  • Hofheim, DE (2004 - 2015)
  • Frankfurt-am-Main, DE (2013 - 2024)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Multispecific Binding Proteins
P2Y12 Antagonists
Pyrazole Derivatives
Fused Pyrroledicarboxamides
Amino Alcohols
Heterocyclic Compounds
Integrin Receptor Antagonists
Aryl-Substituted Polycyclic Amines
Pharmaceutical Preparations
Medicaments
Aryl-Substituted Heterocycles
Beta-Amino Acid Derivatives
28 patents (USPTO):Explore Patents

Title: Gerhard Hessler - Innovative Inventor from Hofheim

Introduction: Gerhard Hessler is a renowned inventor hailing from Hofheim, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Gerhard Hessler holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Gerhard Hessler has worked with leading research institutions and universities to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Gerhard Hessler has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life and make a difference in the world.

Conclusion: Gerhard Hessler's passion for innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology and science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…